Condition
Microfluidics
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Sperm Selection For Icsi
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Unknown1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Sperm Selection For Icsi1
Active Sponsors
- CREA Medicina de la Reproducción SL1
Top Investigators
CREA. Medicina de la Reproducción S.L.
Related Conditions
- Sperm1
- Intracytoplasmic Sperm Injection1